Annual Shareholders Equity
$11.46 M
-$3.40 M-22.88%
June 30, 2024
Summary
- As of February 7, 2025, NNVC annual stockholders equity is $11.46 million, with the most recent change of -$3.40 million (-22.88%) on June 30, 2024.
- During the last 3 years, NNVC annual shareholders equity has fallen by -$18.45 million (-61.67%).
- NNVC annual shareholders equity is now -63.93% below its all-time high of $31.79 million, reached on June 30, 2015.
Performance
NNVC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$10.11 M
-$1.36 M-11.83%
September 1, 2024
Summary
- As of February 7, 2025, NNVC quarterly stockholders equity is $10.11 million, with the most recent change of -$1.36 million (-11.83%) on September 1, 2024.
- Over the past year, NNVC quarterly shareholders equity has dropped by -$543.80 thousand (-5.11%).
- NNVC quarterly shareholders equity is now -72.55% below its all-time high of $36.83 million, reached on September 30, 2014.
Performance
NNVC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NNVC Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.9% | -5.1% |
3 y3 years | -61.7% | -32.0% |
5 y5 years | +8.2% | -32.0% |
NNVC Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -61.7% | at low | -61.8% | at low |
5 y | 5-year | -61.7% | +8.2% | -68.3% | +30.9% |
alltime | all time | -63.9% | >+9999.0% | -72.5% | +4327.4% |
NanoViricides Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $10.11 M(-11.8%) |
Jun 2024 | $11.46 M(-22.9%) | $11.46 M(+7.6%) |
Mar 2024 | - | $10.65 M(-14.5%) |
Dec 2023 | - | $12.45 M(-4.0%) |
Sep 2023 | - | $12.97 M(-12.8%) |
Jun 2023 | $14.87 M(-35.6%) | $14.87 M(-18.4%) |
Mar 2023 | - | $18.23 M(-8.3%) |
Dec 2022 | - | $19.87 M(-7.9%) |
Sep 2022 | - | $21.56 M(-6.6%) |
Jun 2022 | $23.08 M(-22.8%) | $23.08 M(-6.8%) |
Mar 2022 | - | $24.76 M(-6.5%) |
Dec 2021 | - | $26.47 M(-6.5%) |
Sep 2021 | - | $28.31 M(-5.4%) |
Jun 2021 | $29.91 M(+37.5%) | $29.91 M(-6.2%) |
Mar 2021 | - | $31.89 M(+14.9%) |
Dec 2020 | - | $27.75 M(-7.5%) |
Sep 2020 | - | $29.98 M(+37.8%) |
Jun 2020 | $21.76 M(+105.3%) | $21.76 M(+52.0%) |
Mar 2020 | - | $14.31 M(+85.4%) |
Dec 2019 | - | $7.72 M(-15.4%) |
Sep 2019 | - | $9.13 M(-13.9%) |
Jun 2019 | $10.60 M(-40.0%) | $10.60 M(-16.6%) |
Mar 2019 | - | $12.72 M(-8.1%) |
Dec 2018 | - | $13.84 M(-13.4%) |
Sep 2018 | - | $15.98 M(-9.5%) |
Jun 2018 | $17.66 M(-13.1%) | $17.66 M(-7.7%) |
Mar 2018 | - | $19.15 M(+20.3%) |
Dec 2017 | - | $15.92 M(-14.0%) |
Sep 2017 | - | $18.52 M(-8.9%) |
Jun 2017 | $20.32 M(-11.8%) | $20.32 M(-9.3%) |
Mar 2017 | - | $22.41 M(+17.0%) |
Dec 2016 | - | $19.15 M(-5.3%) |
Sep 2016 | - | $20.23 M(-12.2%) |
Jun 2016 | $23.05 M(-27.5%) | $23.05 M(-3.9%) |
Mar 2016 | - | $23.98 M(-15.5%) |
Dec 2015 | - | $28.38 M(-7.6%) |
Sep 2015 | - | $30.71 M(-3.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | $31.79 M(+36.0%) | $31.79 M(-0.2%) |
Mar 2015 | - | $31.86 M(+4.4%) |
Dec 2014 | - | $30.51 M(-17.2%) |
Sep 2014 | - | $36.83 M(+57.6%) |
Jun 2014 | $23.37 M(+191.8%) | $23.37 M(-27.0%) |
Mar 2014 | - | $32.03 M(+213.7%) |
Dec 2013 | - | $10.21 M(-13.1%) |
Sep 2013 | - | $11.75 M(+46.7%) |
Jun 2013 | $8.01 M(-42.2%) | $8.01 M(-20.9%) |
Mar 2013 | - | $10.12 M(-28.8%) |
Dec 2012 | - | $14.21 M(+11.1%) |
Sep 2012 | - | $12.80 M(-7.6%) |
Jun 2012 | $13.85 M(+36.2%) | $13.85 M(+2.1%) |
Mar 2012 | - | $13.57 M(+9.6%) |
Dec 2011 | - | $12.39 M(+8.8%) |
Sep 2011 | - | $11.39 M(+11.9%) |
Jun 2011 | $10.17 M(+56.0%) | $10.17 M(+12.4%) |
Mar 2011 | - | $9.05 M(-3.4%) |
Dec 2010 | - | $9.37 M(+16.7%) |
Sep 2010 | - | $8.03 M(+23.2%) |
Jun 2010 | $6.52 M(+162.3%) | $6.52 M(+83.5%) |
Mar 2010 | - | $3.55 M(-18.3%) |
Dec 2009 | - | $4.35 M(-13.3%) |
Sep 2009 | - | $5.01 M(+101.8%) |
Jun 2009 | $2.49 M(+460.2%) | $2.49 M(+31.2%) |
Mar 2009 | - | $1.90 M(-26.6%) |
Dec 2008 | - | $2.58 M(-18.0%) |
Sep 2008 | - | $3.15 M(+610.0%) |
Jun 2008 | $443.70 K(-11.3%) | $443.70 K(-67.8%) |
Mar 2008 | - | $1.38 M(-35.1%) |
Dec 2007 | - | $2.12 M(-9.3%) |
Sep 2007 | - | $2.34 M(+367.1%) |
Jun 2007 | $500.30 K(-59.6%) | $500.30 K(+119.1%) |
Mar 2007 | - | $228.30 K(-75.9%) |
Dec 2006 | - | $945.40 K(-40.8%) |
Sep 2006 | - | $1.60 M(+29.0%) |
Jun 2006 | $1.24 M(-1976.5%) | $1.24 M |
Jun 2005 | -$66.00 K | - |
FAQ
- What is NanoViricides annual stockholders equity?
- What is the all time high annual shareholders equity for NanoViricides?
- What is NanoViricides annual shareholders equity year-on-year change?
- What is NanoViricides quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NanoViricides?
- What is NanoViricides quarterly shareholders equity year-on-year change?
What is NanoViricides annual stockholders equity?
The current annual shareholders equity of NNVC is $11.46 M
What is the all time high annual shareholders equity for NanoViricides?
NanoViricides all-time high annual stockholders equity is $31.79 M
What is NanoViricides annual shareholders equity year-on-year change?
Over the past year, NNVC annual stockholders equity has changed by -$3.40 M (-22.88%)
What is NanoViricides quarterly stockholders equity?
The current quarterly shareholders equity of NNVC is $10.11 M
What is the all time high quarterly shareholders equity for NanoViricides?
NanoViricides all-time high quarterly stockholders equity is $36.83 M
What is NanoViricides quarterly shareholders equity year-on-year change?
Over the past year, NNVC quarterly stockholders equity has changed by -$543.80 K (-5.11%)